17,245 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, HoldingsChannel reports. The firm acquired 17,245 shares of the medical equipment provider’s stock, valued at approximately $8,540,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Geode Capital Management LLC boosted its stake in Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock worth $4,039,200,000 after buying an additional 243,802 shares during the period. Invesco Ltd. boosted its stake in Intuitive Surgical by 7.7% during the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock worth $2,165,184,000 after buying an additional 295,025 shares during the period. Northern Trust Corp boosted its stake in Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider’s stock worth $1,889,126,000 after buying an additional 494,496 shares during the period. Capital Research Global Investors boosted its stake in Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after buying an additional 687,906 shares during the period. Finally, GAMMA Investing LLC boosted its stake in Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock worth $14,999,630,000 after buying an additional 3,022,979 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 0.4%

Shares of NASDAQ:ISRG opened at $493.95 on Tuesday. The firm’s 50 day moving average price is $528.51 and its 200 day moving average price is $534.63. The stock has a market cap of $177.07 billion, a price-to-earnings ratio of 68.89, a price-to-earnings-growth ratio of 5.20 and a beta of 1.64. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter last year, the company earned $1.78 earnings per share. The firm’s revenue for the quarter was up 21.4% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the firm’s stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company’s stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,610 shares of company stock valued at $3,858,340. 0.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating and lowered their target price for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Royal Bank Of Canada increased their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 23rd. Truist Financial increased their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Citigroup reissued a “buy” rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $592.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.